Fertility Clock Headlines, Fertility Headlines

FDA Warns Against Procedure to Remove Uterine Fibroids; Says it Could Spread Hidden Cancer

The Food and Drug Administration on Thursday took the rare step of urging doctors to stop performing a surgical procedure used on tens of thousands of women each year to remove uterine growths, saying the practice risks spreading hidden cancers within a woman’s body.

Fertility Clock Headlines, Fertility Headlines

FDA to Review Experimental Fertility Treatment

The Food and Drug Administration has accepted for review Merck & Co. Inc.’s new drug application for an investigational fertility treatment.  Merck (NYSE:MRK) is seeking FDA approval of corifollitropin alfa for controlled ovarian stimulation in women participating in assisted reproductive technology.

Fertility Clock Headlines, Fertility Headlines

Can an Antibacterial Ingredient Be the Cause of the Rise of Infertility

Can an anti-bacterial ingredient be some of the cause of infertility? Fox2now reports today that the FDA is now reevaluating the ingredient used in 75 percent of anti-bacterial liquid soaps and body washes sold in the United States. This chemical is also found on kitchen counters, baby bassinets and most hand and body soap.

Fertility Clock Headlines, Fertility Headlines

Will This Pill Fix Your Sex Life?

Pharma’s race for a ‘pink viagra’ finally has a winner, and the promises for it are grand. Osphena, as the recently FDA-approved drug is called, is the newest answer for painful sex. The drug’s creator, pharmaceutical company Shionogi, Inc., is particularly interested in the more than 64 million U.S. women who have hit menopause, half of whom, it claims, could use the drug. In theory, that’s a lot of women who could be having a lot better sex, and soon.

Fertility Clock Headlines, Fertility Headlines

FDA Warns Health Professionals to Halt Use of Other-Sonic Generic Ultrasound Transmission Gel

An FDA press release reports, “U.S. Marshals, acting at the request of the Food and Drug Administration, have seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J., after an FDA analysis found that product samples contained dangerous bacteria. The agency reports that at least 16 patients from one hospital were infected with the bacteria.